Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bile secretion and hepatobiliary secretory machinery refers to the integrated system of transporters, enzymes, and regulatory proteins responsible for the production and flow of bile from the liver into the gastrointestinal tract (Boyer JL, 2013, Comprehensive Physiology). This machinery primarily involves hepatocytes and cholangiocytes, utilizing ATP-binding cassette (ABC) transporters such as the Bile Salt Export Pump (BSEP/ABCB11), Multidrug Resistance-associated Protein 2 (MRP2/ABCC2), and Multidrug Resistance Protein 3 (MDR3/ABCB4) to move bile acids, bilirubin, and phospholipids across the canalicular membrane (Trauner M & Boyer JL, 2003, Physiological Reviews). This process is essential for the digestion and absorption of dietary fats, the excretion of endogenous waste products and xenobiotics, and the maintenance of systemic cholesterol homeostasis. Dysregulation of this machinery leads to cholestatic liver diseases, characterized by impaired bile flow and the accumulation of toxic bile acids, which can cause progressive liver damage, fibrosis, and cirrhosis (Klaassen CD & Aleksunes LM, 2010, Pharmacological Reviews). Therapeutic strategies often target specific components of this system, such as the Farnesoid X Receptor (FXR) to regulate bile acid synthesis or the Ileal Bile Acid Transporter (IBAT) to reduce the enterohepatic circulation of bile salts (StatPearls, 2023, Physiology, Bile Secretion).
Modulation of bile acid synthesis and transport via Farnesoid X Receptor (FXR) agonism, inhibition of Ileal Bile Acid Transporters (IBAT), or induction of phase II detoxifying enzymes and apical transporters like MRP2 and BSEP (Boyer JL, 2013, Comprehensive Physiology).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile secretion and hepatobiliary secretory machinery.